A Dark Vector Cognition product

Item 4. Controls and Procedures.

3K characters. Original on sec.gov ·

Item 4. Controls and Procedures.

Controls and Procedures.

We,

under the

supervision and

with the

participation of

our management,

including our

Chief Executive

Officer and

Chief Financial

Officer,

have

evaluated

the

effectiveness

of

the design

and

operation

of

our

disclosure

controls

and

procedures

(as

defined

in

Rule

13a-15(e)

under

the

Securities

Exchange

Act

of

1934).

Based

on

our

evaluation,

our

Chief

Executive

Officer

and

Chief

Financial

Officer

have

concluded

that,

as

of

November

27,

2022,

our

disclosure

controls

and

procedures

were

effective

to

ensure

that

information required to

be disclosed by us

in reports that we

file or submit under

the Securities Exchange Act

of 1934 is (1)

recorded,

processed, summarized,

and reported

within the

time periods

specified in

Securities and

Exchange Commission

rules and

forms, and

(2)

accumulated

and

communicated

to

our

management,

including

our

Chief

Executive

Officer

and

Chief

Financial

Officer,

in

a

manner that allows timely decisions regarding required disclosure.

There were no changes in our internal

control over financial reporting (as defined

in Rule 13a-15(f) under the Securities Exchange

Act

of

during

the

quarter

ended

November

27,

2022

that

materially

affected,

or

are

reasonably

likely

to

materially

affect,

our

internal control over financial reporting.

PART

II.

OTHER INFORMATION

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

The

following

table

sets forth

information

with

respect

to

shares

of

our

common

stock

that we

purchased

during

the quarter

ended

November 27, 2022:

Period

Total

Number

of Shares

Purchased (a)

Average

Price Paid

Per Share

Total

Number of Shares

Purchased as Part of a Publicly

Announced Program (b)

Maximum Number of Shares

that may yet be Purchased

Under the Program (b)

August 29, 2022 -

October 2, 2022

1,888,000

$

76.66

1,888,000

94,104,938

October 3, 2022 -

October 30, 2022

1,905,000

77.19

1,905,000

92,199,938

October 31, 2022 -

November 27, 2022

1,378,000

78.53

1,378,000

90,821,938

Total

5,171,000

$

77.35

5,171,000

90,821,938

(a)

The total number

of shares purchased

includes shares of

common stock withheld

for the payment

of withholding taxes

upon the distribution

of

deferred option units.

(b)

On June

27, 2022,

our Board

of Directors

approved a

new authorization

for the

repurchase of

up to

100,000,000 shares

of our

common stock

and terminated

the prior

authorization. Purchases

can be

made in

the open

market or

in privately

negotiated transactions,

including the

use of

call options

and other

derivative instruments,

Rule 10b5-1

trading plans,

and accelerated

repurchase programs.

The Board

did not

specify an

expiration date for the authorization.

PART

II. OTHER INFORMATION

Previous: Item 3. Quantitative and Qualitative Disclosures About Market Risk. · Next: Item 6. Exhibits.